Covidien casts off EU incontinence business
This article was originally published in Clinica
Executive Summary
Covidien is set to divest its European incontinence business to an unnamed private French company. The deal, which is expected to close in the second quarter of 2008, will see the anonymous buyer rename the business Lille Healthcare - the incontinence arm is currently headquartered in Lille, France. The business was part of Covidien's medical supplies segment but is now considered non-core to Covidien's healthcare plan, a spokesperson for the company told Clinica. In fiscal 2007, sales from the European incontinence products made $109m, around 11% of the overall sales made by the medical supplies business, which generated $993m in revenue during fiscal 2007. Financial terms of the deal were not disclosed.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.